This issue of the British Journal of Cancer contains four reports showing a lack of mutation of Bcl10 in genomic DNA from malignancies of different histological subtypes. These data appear to be at variance with our original report implicating Bcl10 mutations in the pathogenesis of a wide range of turnours . However, from our further work it now seems that at least some of the Bcl10 abnormalities, originally described as mutations, in fact represented post-transcriptional RNA modification of Bcl10 and are not encoded in genomic DNA.
role in the apoptotic cascade, and from its involvement in the chromosomal translocation it was anticipated that Bcl10, like Bcl2, would be anti-apoptotic. However, wild-type Bcl10 is proapoptotic and has the features of a tumour suppressor gene (Koseki et al, 1999; Thome et al, 1999; Willis et al, 1999; Yan et al, 1999; Zhang et al, 1999) .
We therefore sought Bcl10 mutations first in cDNA clones from one MALT lymphoma with t(1;14)(p22:q32). These comprised point mutations, which were often multiple, deletions at the exon 3-4 boundary, and insertions and deletions within two homopolymeric runs of eight adenines and seven thymidines. An identical spectrum of cDNA abnormalities has been detected independently in other cases of t(1;14)(p22;q32) MALT lymphoma (Zhang et al, 1999) , making it unlikely that all these changes represented polymerase chain reaction or cloning artefacts. Thus, in MALT lymphoma with t(1;14)(p22;q32) there were multiple and ongoing Bcl10 abnormalities. We assumed initially that these reflected the indolent behaviour of MALT lymphoma and that with further in vivo selection, a dominant clone would ultimately emerge.
However, we have now sequenced multiple cDNA clones from various malignant cell lines, primary lymphoid tumours and normal tissues and found all three types of abnormality at varying frequency in all instances. The data presented originally ( Table 2 in Willis et al, 1999) referred to cDNA clones from six malignant cell lines, including Tera-1, Tera-2, GCT-44 and from three mesothelioma lines, and in all, multiple Bcl10 abnormalities were detected. In contrast, a much lower mutational frequency was detected in genomic DNA. Also, multiple cDNA abnormalities have been detected in some cell lines, including the Tera-2 cell line in the presence of apparently normal germline DNA .
To summarize the three types of deviation from the wild-type sequence:
a. Bcl10 utilizes three alternative splice sites at the exon 3-4 boundary b. Alterations within the homopolymeric runs of eight As and seven Ts are common in Bcl10 cDNAs, and in most instances are not templated c. Bcl10 point mutations are multiple and ongoing. Whether all point mutations are present in genomic DNA or whether some are non-templated is not clear.
Bcl10 therefore appears to undergo what has been termed 'molecular misreading ' (van Leeuwen et al, 1998) and at least some of the discrepancies between our initial data and those reported here can be ascribed to our use of cDNA rather than genomic DNA.
